Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability in males. It is an X-linked trinucleotide-repeat disorder due to mutation in the FMR1 gene at Xq27.3.
Genetic defect and pathogenesis
The FMR1 gene contains CGG repeats in its 5′ untranslated region.
Normal allele: about 6-55 CGG repeats.
Premutation:55-200 repeats. Carriers are usually not affected with classical FXS.
Full mutation: usually >200 repeats, sometimes expanding to several thousand.
The full mutation causes hypermethylation of the 5′ region and promoter of FMR1.
This epigenetically silences transcription of FMR1, resulting in deficiency of FMRP (fragile X messenger ribonucleoprotein).
FMRP normally regulates transport and translation of mRNAs at neuronal synapses. Its loss leads to abnormal synaptic development and neurodevelopmental impairment.
Inheritance and anticipation
Shows an unusual X-linked inheritance pattern with anticipation: disease becomes more severe or more frequent in later generations because the CGG repeat expands.
Premutations commonly expand to full mutations during maternal transmission/oogenesis, not during spermatogenesis.
Thus, a carrier woman can have sons with a full mutation who are severely affected.
Females are less severely affected because of the second normal X chromosome; phenotype varies with skewed X-inactivation.
Clinical features
Affected males:
Moderate to severe intellectual disability
Delayed speech and developmental delay
Autism spectrum disorder or autistic behavior
Behavioral abnormalities, including hyperactivity, anxiety, poor eye contact, and hand flapping
Long narrow face
Large, protruding ears
Macroorchidism after puberty
May have connective-tissue manifestations such as joint laxity and mitral valve prolapse
Affected females:
About 30%-50% of female full-mutation carriers may show intellectual disability or behavioral features, usually milder than in males.
Fragile site and diagnosis
Historically, the syndrome was recognized by a fragile-appearing constriction or break at the distal long arm of the X chromosome when cells were cultured in folate-deficient medium. This is no longer the diagnostic method.
Diagnosis: DNA testing for FMR1 CGG-repeat expansion, commonly PCR-based testing with methylation analysis.
Premutation-associated disorders
Unlike the full mutation, the premutation is generally not methylated and FMR1 continues to be transcribed. The expanded CGG-containing RNA has a toxic gain-of-function effect through sequestration of RNA-binding proteins.